Covered recipient · General Payments record
BRADLEY G NEUENSCHWANDER
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2018–2024
$2,890.54
- Reported across 177 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $419.79 | 28 |
| Education | $64.95 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $169.36 | 17 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $85.17 | 3 |
| Janssen Biotech, Inc. | $82.64 | 2 |
| UCB, Inc. | $29.96 | 1 |
| Biofrontera Inc. | $24.64 | 1 |
| Amgen Inc. | $21.32 | 1 |
| Lilly USA, LLC | $20.64 | 1 |
| LEO Pharma Inc. | $19.94 | 1 |
| Arcutis Biotherapeutics, Inc. | $17.34 | 1 |
| Incyte Corporation | $13.73 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.58 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105112382 | CMS |
| ABBVIE INC. | $0.70 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105112384 | CMS |
| ABBVIE INC. | $18.60 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105112386 | CMS |
| ABBVIE INC. | $23.81 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105112388 | CMS |
| ABBVIE INC. | $5.82 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105112390 | CMS |
| ABBVIE INC. | $22.91 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105112392 | CMS |
| ABBVIE INC. | $0.45 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105112394 | CMS |
| ABBVIE INC. | $26.76 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105112396 | CMS |
| ABBVIE INC. | $8.66 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105112398 | CMS |
| ABBVIE INC. | $1.36 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105112400 | CMS |
| ABBVIE INC. | $4.24 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105112402 | CMS |
| ABBVIE INC. | $5.37 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105112404 | CMS |
| ABBVIE INC. | $4.03 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105112406 | CMS |
| ABBVIE INC. | $5.10 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105112408 | CMS |
| ABBVIE INC. | $5.45 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105112410 | CMS |
| ABBVIE INC. | $1.21 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105112412 | CMS |
| ABBVIE INC. | $20.31 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105112414 | CMS |
| Amgen Inc. | $21.32 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117338323 | CMS |
| Arcutis Biotherapeutics, Inc. | $17.34 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121037518 | CMS |
| Biofrontera Inc. | $24.64 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111024227 | CMS |
| Incyte Corporation | $13.73 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141250688 | CMS |
| Janssen Biotech, Inc. | $17.69 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078782977 | CMS |
| Janssen Biotech, Inc. | $64.95 | 05/06/2024 | Education | Undisputed | 01/23/2026 | 1078782945 | CMS |
| LEO Pharma Inc. | $19.94 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152644109 | CMS |
| Lilly USA, LLC | $20.64 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136072381 | CMS |
| Novartis Pharmaceuticals Corporation | $27.52 | 01/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087069748 | CMS |
| Novartis Pharmaceuticals Corporation | $30.18 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087069750 | CMS |
| Novartis Pharmaceuticals Corporation | $27.47 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087069752 | CMS |
| UCB, Inc. | $29.96 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143112467 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.